| Name | Title | Contact Details |
|---|
Woodside Assisted Living Cmnty is a Springfield, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Sensei is an evidenced-based company that develops technology and offers healthier living programs and services to help people find greater wellbeing. Its first retreat is located at the Sensei Lānaʻi, A Four Seasons Resort on Larry Ellison`s secluded Hawaiian island of Lānaʻi, is where people come to learn the Sensei Way philosophy in the most luxurious and inspiring settings. Each guest`s stay is highly customized to help align their actions with their intentions by offering private wellness consultations, small indoor and outdoor classes, relaxing treatments in individual spa hales, outdoor adventures and innovative dining guided by the Sensei nutritional philosophy.
Brighton Health Group is BHPS`s parent company whose approach it is to create an ecosystem in which everyone`s success is contingent upon better health for patients. BHG`s businesses collaborate with physicians, payors and plan sponsors to align the economics with better results, enabling consumers to make better decisions. Combining expertise in healthcare economics with operations drives transformation across the healthcare value chain. BHG aligns financial incentives with quality outcomes and clinical accountability. This formula is building a sustainable business model based on shared rewards between the providers, payors, and health plan sponsors.
At Footprints to Recovery, our mission is to transform your life of addiction to a life of hope through inspiration, education, and support. We`re an individual focused and evidenced based addiction rehabilitation center, that emphasizes meaningful connections in recovery. We are conveniently located in Hamilton, NJ and Arlington Heights, IL.
WAVE Life Sciences is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering exceptional treatment options for patients. Given the unique versatility of its chemistry platform, WAVE`s pipeline will span multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded RNAi.